Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections

NCT07256405 is registered in ClinicalTrials.gov with Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer as lead sponsor.

NCT NCT07256405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07256405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Contribution of Metagenomic Sequencing Using Nanopore Technology to the Management of Post-traumatic Bone and Joint Infections
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Phase
Observational
Overall status
Completed
Start date
March 11, 2024
Completion date
December 31, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone, fracture, infection